Investigation of the cytotoxicity induced by didocosahexaenoin, an omega 3 derivative, in human prostate carcinoma cell lines

The aim of the present study was to investigate the cytotoxicity induced by an omega-3 derivative, didocosahexaenoin (Dido) on human prostate carcinoma cells and to compare the cytotoxicity to that of docosahexaenoic acid (DHA). Different carcinoma- and non-carcinoma cells were exposed to various co...

Full description

Bibliographic Details
Main Authors: Glenn F. Robinson, Kartheek KY. Sooda, Roger M. Phillips, Simon J. Allison, Farideh A. Javid
Format: Article
Language:English
Published: Elsevier 2022-01-01
Series:Current Research in Pharmacology and Drug Discovery
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590257122000050
_version_ 1811293856787857408
author Glenn F. Robinson
Kartheek KY. Sooda
Roger M. Phillips
Simon J. Allison
Farideh A. Javid
author_facet Glenn F. Robinson
Kartheek KY. Sooda
Roger M. Phillips
Simon J. Allison
Farideh A. Javid
author_sort Glenn F. Robinson
collection DOAJ
description The aim of the present study was to investigate the cytotoxicity induced by an omega-3 derivative, didocosahexaenoin (Dido) on human prostate carcinoma cells and to compare the cytotoxicity to that of docosahexaenoic acid (DHA). Different carcinoma- and non-carcinoma cells were exposed to various concentrations of omega-3 compounds at varying exposure times and the cytotoxicity was measured by MTT assay. The mechanism of Dido-induced apoptosis was investigated in prostate carcinoma cells. Dido induced stronger cytotoxicity than DHA in human prostate carcinoma cells in a dose- and time-dependent manner. Dido was also more selective and potent in inducing cytotoxicity in prostate carcinoma cells than other carcinoma cell lines tested. Pre-treatment with Dido increased the level of reactive oxygen species (ROS) in prostate carcinoma cells. Pre-treatment with various antioxidants reduced the cytotoxicity induced by Dido. Pre-treatment with Dido ≥30 ​μM also induced apoptosis which was suggested to involve an externalisation of phosphatidyl serine, a significant increase in the mitochondrial membrane potential (p ​< ​0.01) and the level of activated caspase 3/7 (p ​< ​0.05) in prostate carcinoma cells. This study is the first to show that Dido induced cytotoxicity with high selectivity and higher potency than DHA in human prostate carcinoma cells. The mechanism of action is likely to involve an increase in the level of ROS, loss in the mitochondrial membrane potential as well as externalisation of phosphatidyl serine and increase in the caspase 3/7 activity. Dido may have potential to be used for the adjuvant therapy or combination therapy with conventional chemotherapeutic drugs.
first_indexed 2024-04-13T05:07:46Z
format Article
id doaj.art-f23216526d6e4bf3bf35173c95cd407f
institution Directory Open Access Journal
issn 2590-2571
language English
last_indexed 2024-04-13T05:07:46Z
publishDate 2022-01-01
publisher Elsevier
record_format Article
series Current Research in Pharmacology and Drug Discovery
spelling doaj.art-f23216526d6e4bf3bf35173c95cd407f2022-12-22T03:01:07ZengElsevierCurrent Research in Pharmacology and Drug Discovery2590-25712022-01-013100085Investigation of the cytotoxicity induced by didocosahexaenoin, an omega 3 derivative, in human prostate carcinoma cell linesGlenn F. Robinson0Kartheek KY. Sooda1Roger M. Phillips2Simon J. Allison3Farideh A. Javid4Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield, HD1 3DH, UKDepartment of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield, HD1 3DH, UKDepartment of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield, HD1 3DH, UKDepartment of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield, HD1 3DH, UKCorresponding author.; Department of Pharmacy, School of Applied Sciences, University of Huddersfield, Queensgate, Huddersfield, HD1 3DH, UKThe aim of the present study was to investigate the cytotoxicity induced by an omega-3 derivative, didocosahexaenoin (Dido) on human prostate carcinoma cells and to compare the cytotoxicity to that of docosahexaenoic acid (DHA). Different carcinoma- and non-carcinoma cells were exposed to various concentrations of omega-3 compounds at varying exposure times and the cytotoxicity was measured by MTT assay. The mechanism of Dido-induced apoptosis was investigated in prostate carcinoma cells. Dido induced stronger cytotoxicity than DHA in human prostate carcinoma cells in a dose- and time-dependent manner. Dido was also more selective and potent in inducing cytotoxicity in prostate carcinoma cells than other carcinoma cell lines tested. Pre-treatment with Dido increased the level of reactive oxygen species (ROS) in prostate carcinoma cells. Pre-treatment with various antioxidants reduced the cytotoxicity induced by Dido. Pre-treatment with Dido ≥30 ​μM also induced apoptosis which was suggested to involve an externalisation of phosphatidyl serine, a significant increase in the mitochondrial membrane potential (p ​< ​0.01) and the level of activated caspase 3/7 (p ​< ​0.05) in prostate carcinoma cells. This study is the first to show that Dido induced cytotoxicity with high selectivity and higher potency than DHA in human prostate carcinoma cells. The mechanism of action is likely to involve an increase in the level of ROS, loss in the mitochondrial membrane potential as well as externalisation of phosphatidyl serine and increase in the caspase 3/7 activity. Dido may have potential to be used for the adjuvant therapy or combination therapy with conventional chemotherapeutic drugs.http://www.sciencedirect.com/science/article/pii/S2590257122000050DidocosahexaenoinOmega-3 fatty acidsProstate cancerROSCaspase 3/7
spellingShingle Glenn F. Robinson
Kartheek KY. Sooda
Roger M. Phillips
Simon J. Allison
Farideh A. Javid
Investigation of the cytotoxicity induced by didocosahexaenoin, an omega 3 derivative, in human prostate carcinoma cell lines
Current Research in Pharmacology and Drug Discovery
Didocosahexaenoin
Omega-3 fatty acids
Prostate cancer
ROS
Caspase 3/7
title Investigation of the cytotoxicity induced by didocosahexaenoin, an omega 3 derivative, in human prostate carcinoma cell lines
title_full Investigation of the cytotoxicity induced by didocosahexaenoin, an omega 3 derivative, in human prostate carcinoma cell lines
title_fullStr Investigation of the cytotoxicity induced by didocosahexaenoin, an omega 3 derivative, in human prostate carcinoma cell lines
title_full_unstemmed Investigation of the cytotoxicity induced by didocosahexaenoin, an omega 3 derivative, in human prostate carcinoma cell lines
title_short Investigation of the cytotoxicity induced by didocosahexaenoin, an omega 3 derivative, in human prostate carcinoma cell lines
title_sort investigation of the cytotoxicity induced by didocosahexaenoin an omega 3 derivative in human prostate carcinoma cell lines
topic Didocosahexaenoin
Omega-3 fatty acids
Prostate cancer
ROS
Caspase 3/7
url http://www.sciencedirect.com/science/article/pii/S2590257122000050
work_keys_str_mv AT glennfrobinson investigationofthecytotoxicityinducedbydidocosahexaenoinanomega3derivativeinhumanprostatecarcinomacelllines
AT kartheekkysooda investigationofthecytotoxicityinducedbydidocosahexaenoinanomega3derivativeinhumanprostatecarcinomacelllines
AT rogermphillips investigationofthecytotoxicityinducedbydidocosahexaenoinanomega3derivativeinhumanprostatecarcinomacelllines
AT simonjallison investigationofthecytotoxicityinducedbydidocosahexaenoinanomega3derivativeinhumanprostatecarcinomacelllines
AT faridehajavid investigationofthecytotoxicityinducedbydidocosahexaenoinanomega3derivativeinhumanprostatecarcinomacelllines